Abstract
Background/Purpose: Deregulation of metabolic pathways is one of the hallmarks of cancer progression. Connective tissue growth factor (CTGF/CCN2) acts as a tumor suppressor in oral squamous cell carcinoma (OSCC). However, the role of CTGF in modulating cancer metabolism is still unclear. Methods: OSCC cells stably overexpressing CTGF (SAS/CTGF) and shRNA against CTGF (TW2.6/shCTGF) were established. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were examined by the Seahorse XF24 analyzer. The expression of CTGF and mitochondrial biogenesis related genes was measured by real-time polymerase chain reaction or Western blot analysis. Results: CTGF decreased OCR, ECAR, adenosine triphosphate (ATP) generation, mitochondrial DNA (mtDNA), and mitochondrial transcription factor A (mtTFA) protein expression in OSCC cells. Overexpression of mtTFA restored CTGF-decreased OCR, ECAR, mtDNA copy number, migration and invasion of SAS/CTGF cells. Immunoprecipitation assay showed a higher level of ubiquitinated mtTFA protein after CTGF treatment. MG132, an inhibitor of proteasomal degradation, reversed the effect of CTGF on mtTFA protein expression in SAS cells. Conclusion: CTGF can decrease glycolysis, mitochondrial oxidative phosphorylation, ATP generation, and mtDNA copy number by increasing mtTFA protein degradation through ubiquitin proteasome pathway and in turn reduces migration and invasion of OSCC cells. Therefore, CTGF may be developed as a potential additive therapeutic drug for oral cancer in the near future.
Original language | English |
---|---|
Pages (from-to) | 212-219 |
Number of pages | 8 |
Journal | Journal of the Formosan Medical Association |
Volume | 117 |
Issue number | 3 |
DOIs | |
State | Published - 03 2018 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:
© 2017
Keywords
- CTGF
- Metabolism
- Mitochondrion
- OSCC
- mtTFA
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma'. Together they form a unique fingerprint.
View full fingerprint
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Lai, W. T., Li, Y. J., Wu, S. B., Yang, C. N., Wu, T. S., Wei, Y. H., & Deng, Y. T. (2018). Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma. Journal of the Formosan Medical Association, 117(3), 212-219. https://doi.org/10.1016/j.jfma.2017.04.003
Lai, Wei Ting ; Li, Yue Ju ; Wu, Shi Bei et al. / Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma. In: Journal of the Formosan Medical Association. 2018 ; Vol. 117, No. 3. pp. 212-219.
@article{c023f7537b6f4478a3b516e908998c31,
title = "Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma",
abstract = "Background/Purpose: Deregulation of metabolic pathways is one of the hallmarks of cancer progression. Connective tissue growth factor (CTGF/CCN2) acts as a tumor suppressor in oral squamous cell carcinoma (OSCC). However, the role of CTGF in modulating cancer metabolism is still unclear. Methods: OSCC cells stably overexpressing CTGF (SAS/CTGF) and shRNA against CTGF (TW2.6/shCTGF) were established. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were examined by the Seahorse XF24 analyzer. The expression of CTGF and mitochondrial biogenesis related genes was measured by real-time polymerase chain reaction or Western blot analysis. Results: CTGF decreased OCR, ECAR, adenosine triphosphate (ATP) generation, mitochondrial DNA (mtDNA), and mitochondrial transcription factor A (mtTFA) protein expression in OSCC cells. Overexpression of mtTFA restored CTGF-decreased OCR, ECAR, mtDNA copy number, migration and invasion of SAS/CTGF cells. Immunoprecipitation assay showed a higher level of ubiquitinated mtTFA protein after CTGF treatment. MG132, an inhibitor of proteasomal degradation, reversed the effect of CTGF on mtTFA protein expression in SAS cells. Conclusion: CTGF can decrease glycolysis, mitochondrial oxidative phosphorylation, ATP generation, and mtDNA copy number by increasing mtTFA protein degradation through ubiquitin proteasome pathway and in turn reduces migration and invasion of OSCC cells. Therefore, CTGF may be developed as a potential additive therapeutic drug for oral cancer in the near future.",
keywords = "CTGF, Metabolism, Mitochondrion, OSCC, mtTFA",
author = "Lai, {Wei Ting} and Li, {Yue Ju} and Wu, {Shi Bei} and Yang, {Cheng Ning} and Wu, {Tai Sheng} and Wei, {Yau Huei} and Deng, {Yi Ting}",
note = "Publisher Copyright: {\textcopyright} 2017",
year = "2018",
month = mar,
doi = "10.1016/j.jfma.2017.04.003",
language = "英语",
volume = "117",
pages = "212--219",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
number = "3",
}
Lai, WT, Li, YJ, Wu, SB, Yang, CN, Wu, TS, Wei, YH & Deng, YT 2018, 'Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma', Journal of the Formosan Medical Association, vol. 117, no. 3, pp. 212-219. https://doi.org/10.1016/j.jfma.2017.04.003
Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma. / Lai, Wei Ting; Li, Yue Ju; Wu, Shi Bei et al.
In: Journal of the Formosan Medical Association, Vol. 117, No. 3, 03.2018, p. 212-219.
Research output: Contribution to journal › Journal Article › peer-review
TY - JOUR
T1 - Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma
AU - Lai, Wei Ting
AU - Li, Yue Ju
AU - Wu, Shi Bei
AU - Yang, Cheng Ning
AU - Wu, Tai Sheng
AU - Wei, Yau Huei
AU - Deng, Yi Ting
N1 - Publisher Copyright:© 2017
PY - 2018/3
Y1 - 2018/3
N2 - Background/Purpose: Deregulation of metabolic pathways is one of the hallmarks of cancer progression. Connective tissue growth factor (CTGF/CCN2) acts as a tumor suppressor in oral squamous cell carcinoma (OSCC). However, the role of CTGF in modulating cancer metabolism is still unclear. Methods: OSCC cells stably overexpressing CTGF (SAS/CTGF) and shRNA against CTGF (TW2.6/shCTGF) were established. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were examined by the Seahorse XF24 analyzer. The expression of CTGF and mitochondrial biogenesis related genes was measured by real-time polymerase chain reaction or Western blot analysis. Results: CTGF decreased OCR, ECAR, adenosine triphosphate (ATP) generation, mitochondrial DNA (mtDNA), and mitochondrial transcription factor A (mtTFA) protein expression in OSCC cells. Overexpression of mtTFA restored CTGF-decreased OCR, ECAR, mtDNA copy number, migration and invasion of SAS/CTGF cells. Immunoprecipitation assay showed a higher level of ubiquitinated mtTFA protein after CTGF treatment. MG132, an inhibitor of proteasomal degradation, reversed the effect of CTGF on mtTFA protein expression in SAS cells. Conclusion: CTGF can decrease glycolysis, mitochondrial oxidative phosphorylation, ATP generation, and mtDNA copy number by increasing mtTFA protein degradation through ubiquitin proteasome pathway and in turn reduces migration and invasion of OSCC cells. Therefore, CTGF may be developed as a potential additive therapeutic drug for oral cancer in the near future.
AB - Background/Purpose: Deregulation of metabolic pathways is one of the hallmarks of cancer progression. Connective tissue growth factor (CTGF/CCN2) acts as a tumor suppressor in oral squamous cell carcinoma (OSCC). However, the role of CTGF in modulating cancer metabolism is still unclear. Methods: OSCC cells stably overexpressing CTGF (SAS/CTGF) and shRNA against CTGF (TW2.6/shCTGF) were established. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were examined by the Seahorse XF24 analyzer. The expression of CTGF and mitochondrial biogenesis related genes was measured by real-time polymerase chain reaction or Western blot analysis. Results: CTGF decreased OCR, ECAR, adenosine triphosphate (ATP) generation, mitochondrial DNA (mtDNA), and mitochondrial transcription factor A (mtTFA) protein expression in OSCC cells. Overexpression of mtTFA restored CTGF-decreased OCR, ECAR, mtDNA copy number, migration and invasion of SAS/CTGF cells. Immunoprecipitation assay showed a higher level of ubiquitinated mtTFA protein after CTGF treatment. MG132, an inhibitor of proteasomal degradation, reversed the effect of CTGF on mtTFA protein expression in SAS cells. Conclusion: CTGF can decrease glycolysis, mitochondrial oxidative phosphorylation, ATP generation, and mtDNA copy number by increasing mtTFA protein degradation through ubiquitin proteasome pathway and in turn reduces migration and invasion of OSCC cells. Therefore, CTGF may be developed as a potential additive therapeutic drug for oral cancer in the near future.
KW - CTGF
KW - Metabolism
KW - Mitochondrion
KW - OSCC
KW - mtTFA
UR - http://www.scopus.com/inward/record.url?scp=85018732180&partnerID=8YFLogxK
U2 - 10.1016/j.jfma.2017.04.003
DO - 10.1016/j.jfma.2017.04.003
M3 - 文章
C2 - 28438434
AN - SCOPUS:85018732180
SN - 0929-6646
VL - 117
SP - 212
EP - 219
JO - Journal of the Formosan Medical Association
JF - Journal of the Formosan Medical Association
IS - 3
ER -
Lai WT, Li YJ, Wu SB, Yang CN, Wu TS, Wei YH et al. Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma. Journal of the Formosan Medical Association. 2018 Mar;117(3):212-219. doi: 10.1016/j.jfma.2017.04.003